Skip to main content
Top
Published in: Respiratory Research 1/2020

Open Access 01-12-2020 | Obesity | Research

The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data

Authors: Manuel B. Huber, Christoph Kurz, Florian Kirsch, Larissa Schwarzkopf, Anja Schramm, Reiner Leidl

Published in: Respiratory Research | Issue 1/2020

Login to get access

Abstract

Background

Body mass index (BMI) is an important parameter associated with mortality and health-related quality of life (HRQoL) in chronic obstructive pulmonary disease (COPD). However, informed guidance on stratified weight recommendations for COPD is still lacking. This study aims to determine the association between BMI and HRQoL across different severity grades of COPD to support patient management.

Methods

We use conjunct analysis of claims and survey data based on a German COPD disease management program from 2016 to 2017. The EQ-5D-5L visual analog scale (VAS) and COPD Assessment Test (CAT) are used to measure generic and disease-specific HRQoL. Generalized additive models with smooth functions are implemented to evaluate the relationship between BMI and HRQoL, stratified by COPD severity.

Results

11,577 patients were included in this study. Mean age was 69.4 years and 59% of patients were male. In GOLD grades 1–3, patients with BMI of around 25 had the best generic and disease-specific HRQoL, whereas in GOLD grade 4, obese patients had the best HRQoL using both instruments when controlled for several variables including smoking status, income, COPD severity, comorbidities, emphysema, corticosteroid use, and days spent in hospital.

Conclusion

This real-world analysis shows the non-linear relationship between BMI and HRQoL in COPD. HRQoL of obese patients with mild to severe COPD might improve following weight reduction. For very severe COPD, a negative association of obesity and HRQoL could not be confirmed. The results hint at the need to stratify COPD patients by disease stage for optimal BMI management.
Appendix
Available only for authorised users
Literature
1.
go back to reference Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. CrossRef Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. CrossRef
2.
go back to reference Blanco I, Diego I, Bueno P, Casas-Maldonado F, Miravitlles M. Geographic distribution of COPD prevalence in the world displayed by geographic information system maps. Eur Respir J. 2019;54(1):1900610. CrossRef Blanco I, Diego I, Bueno P, Casas-Maldonado F, Miravitlles M. Geographic distribution of COPD prevalence in the world displayed by geographic information system maps. Eur Respir J. 2019;54(1):1900610. CrossRef
3.
go back to reference Engstrom CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J. 2001;18(1):69–76. CrossRef Engstrom CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J. 2001;18(1):69–76. CrossRef
4.
go back to reference Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. CrossRef Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. CrossRef
5.
go back to reference Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–61. CrossRef Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–61. CrossRef
6.
go back to reference Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61. CrossRef Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61. CrossRef
7.
go back to reference Costanzo P, Cleland JGF, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES, et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort studythe obesity paradox in type 2 diabetes mellitus. Ann Intern Med. 2015;162(9):610–8. CrossRef Costanzo P, Cleland JGF, Pellicori P, Clark AL, Hepburn D, Kilpatrick ES, et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort studythe obesity paradox in type 2 diabetes mellitus. Ann Intern Med. 2015;162(9):610–8. CrossRef
8.
go back to reference Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82. CrossRef Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82. CrossRef
9.
go back to reference Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156. CrossRef Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156. CrossRef
10.
go back to reference Global BMIMC, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86. CrossRef Global BMIMC, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86. CrossRef
11.
go back to reference Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944–53. CrossRef Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944–53. CrossRef
12.
go back to reference Daviglus ML, Liu K, Yan LL, Pirzada A, Garside DB, Schiffer L, et al. Body mass index in middle age and health-related quality of life in older age: the Chicago Heart Association Detection Project in industry study. Arch Intern Med. 2003;163(20):2448–55. CrossRef Daviglus ML, Liu K, Yan LL, Pirzada A, Garside DB, Schiffer L, et al. Body mass index in middle age and health-related quality of life in older age: the Chicago Heart Association Detection Project in industry study. Arch Intern Med. 2003;163(20):2448–55. CrossRef
13.
go back to reference Wee H-L, Cheung Y-B, Loke W-C, Tan C-B, Chow M-H, Li S-C, et al. the association of body mass index with health-related quality of life: an exploratory study in a multiethnic Asian population. Value Health. 2008;11:S105–14. CrossRef Wee H-L, Cheung Y-B, Loke W-C, Tan C-B, Chow M-H, Li S-C, et al. the association of body mass index with health-related quality of life: an exploratory study in a multiethnic Asian population. Value Health. 2008;11:S105–14. CrossRef
14.
go back to reference Adeyemi A, Rascati KL, Lawson KA, Barner JC, Wilson J, Novak S. Evaluating the relationship between body mass index (BMI) and health-related quality of life (HRQoL) of patients With diabetes. Value Health. 2014;17(3):A256–7. CrossRef Adeyemi A, Rascati KL, Lawson KA, Barner JC, Wilson J, Novak S. Evaluating the relationship between body mass index (BMI) and health-related quality of life (HRQoL) of patients With diabetes. Value Health. 2014;17(3):A256–7. CrossRef
15.
go back to reference Laxy M, Teuner C, Holle R, Kurz C. The association between BMI and health-related quality of life in the US population: sex, age and ethnicity matters. Int J Obes (2005). 2018;42(3):318–26. CrossRef Laxy M, Teuner C, Holle R, Kurz C. The association between BMI and health-related quality of life in the US population: sex, age and ethnicity matters. Int J Obes (2005). 2018;42(3):318–26. CrossRef
16.
go back to reference Lin VW, Wong ES, Wright A, Flum DR, Garrison LP Jr, Alfonso-Cristancho R, et al. Association between health-related quality of life and body mass after adjustable gastric banding: a nonlinear approach. Value Health. 2013;16(5):823–9. CrossRef Lin VW, Wong ES, Wright A, Flum DR, Garrison LP Jr, Alfonso-Cristancho R, et al. Association between health-related quality of life and body mass after adjustable gastric banding: a nonlinear approach. Value Health. 2013;16(5):823–9. CrossRef
17.
go back to reference Cardel MI, Jastreboff AM, Kelly AS. Treatment of adolescent obesity in 2020. JAMA. 2019;322(17):1707–8. CrossRef Cardel MI, Jastreboff AM, Kelly AS. Treatment of adolescent obesity in 2020. JAMA. 2019;322(17):1707–8. CrossRef
18.
go back to reference Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387(10031):1947–56. CrossRef Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387(10031):1947–56. CrossRef
19.
go back to reference Gemeinsamer Bundesausschuss. Richtlinie des Gemeinsamen Bundesausschusses zur Zusammenführung der Anforderungen an strukturierte Behandlungsprogramme nach § 137f Absatz 2 SGB V(DMP-Anforderungen-Richtlinie/DMP-A-RL) 2019. Gemeinsamer Bundesausschuss. Richtlinie des Gemeinsamen Bundesausschusses zur Zusammenführung der Anforderungen an strukturierte Behandlungsprogramme nach § 137f Absatz 2 SGB V(DMP-Anforderungen-Richtlinie/DMP-A-RL) 2019.
20.
go back to reference Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358. CrossRef Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358. CrossRef
21.
go back to reference Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. CrossRef Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. CrossRef
22.
go back to reference Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786–97. CrossRef Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786–97. CrossRef
23.
go back to reference Team NGU. National Institute for Health and Care Excellence: Clinical Guidelines. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. 2018. Team NGU. National Institute for Health and Care Excellence: Clinical Guidelines. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. 2018.
24.
go back to reference Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report GOLD executive summary. Am J Respir Critic Care Med. 2017;195(5):557–82. CrossRef Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report GOLD executive summary. Am J Respir Critic Care Med. 2017;195(5):557–82. CrossRef
25.
go back to reference Basch E. Patient-reported outcomes—harnessing patients’ voices to improve clinical care. N Engl J Med. 2017;376(2):105–8. CrossRef Basch E. Patient-reported outcomes—harnessing patients’ voices to improve clinical care. N Engl J Med. 2017;376(2):105–8. CrossRef
26.
go back to reference Nolan CM, Longworth L, Lord J, Canavan JL, Jones SE, Kon SS, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500. CrossRef Nolan CM, Longworth L, Lord J, Canavan JL, Jones SE, Kon SS, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500. CrossRef
27.
go back to reference Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54. CrossRef Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–54. CrossRef
28.
go back to reference Hastie T, Tibshirani R. Generalized additive models. Stat Sci. 1986;1(3):297–310. CrossRef Hastie T, Tibshirani R. Generalized additive models. Stat Sci. 1986;1(3):297–310. CrossRef
29.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. CrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. CrossRef
30.
go back to reference R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria 2018. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria 2018.
31.
go back to reference Miniati M, Bottai M, Pavlickova I, Monti S. Body height as risk factor for emphysema in COPD. Sci Rep. 2016;6(1):36896. CrossRef Miniati M, Bottai M, Pavlickova I, Monti S. Body height as risk factor for emphysema in COPD. Sci Rep. 2016;6(1):36896. CrossRef
32.
go back to reference Ogawa E, Nakano Y, Ohara T, Muro S, Hirai T, Sato S, et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax. 2009;64(1):20–5. CrossRef Ogawa E, Nakano Y, Ohara T, Muro S, Hirai T, Sato S, et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax. 2009;64(1):20–5. CrossRef
33.
go back to reference Sun Y, Milne S, Jaw JE, Yang CX, Xu F, Li X, et al. BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respir Res. 2019;20(1):236. CrossRef Sun Y, Milne S, Jaw JE, Yang CX, Xu F, Li X, et al. BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respir Res. 2019;20(1):236. CrossRef
34.
go back to reference Spelta F, Fratta Pasini AM, Cazzoletti L, Ferrari M. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord EWD. 2018;23(1):15–22. CrossRef Spelta F, Fratta Pasini AM, Cazzoletti L, Ferrari M. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord EWD. 2018;23(1):15–22. CrossRef
35.
go back to reference Kim YW, Lee C-H, Hwang H-G, Kim Y-I, Kim DK, Oh Y-M, et al. Resting hyperinflation and emphysema on the clinical course of COPD. Sci Rep. 2019;9(1):3764. CrossRef Kim YW, Lee C-H, Hwang H-G, Kim Y-I, Kim DK, Oh Y-M, et al. Resting hyperinflation and emphysema on the clinical course of COPD. Sci Rep. 2019;9(1):3764. CrossRef
36.
go back to reference Klooster K, ten Hacken NH, Hartman JE, Sciurba FC, Kerstjens HA, Slebos DJ. Determining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary disease. Respiration. 2015;90(4):306–13. CrossRef Klooster K, ten Hacken NH, Hartman JE, Sciurba FC, Kerstjens HA, Slebos DJ. Determining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary disease. Respiration. 2015;90(4):306–13. CrossRef
37.
go back to reference Kurosaki H, Ishii T, Motohashi N, Motegi T, Yamada K, Kudoh S, et al. Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD. Intern Med (Tokyo, Japan). 2009;48(1):41–8. CrossRef Kurosaki H, Ishii T, Motohashi N, Motegi T, Yamada K, Kudoh S, et al. Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD. Intern Med (Tokyo, Japan). 2009;48(1):41–8. CrossRef
38.
go back to reference Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med. 2010;104(2):275–82. CrossRef Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med. 2010;104(2):275–82. CrossRef
39.
go back to reference Lynch DA, Moore CM, Wilson C, Nevrekar D, Jennermann T, Humphries SM, et al. CT-based visual classification of emphysema: association with mortality in the COPDGene study. Radiology. 2018;288(3):859–66. CrossRef Lynch DA, Moore CM, Wilson C, Nevrekar D, Jennermann T, Humphries SM, et al. CT-based visual classification of emphysema: association with mortality in the COPDGene study. Radiology. 2018;288(3):859–66. CrossRef
40.
go back to reference Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50(3):117–28. CrossRef Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50(3):117–28. CrossRef
41.
go back to reference Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7(7):e39504. CrossRef Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7(7):e39504. CrossRef
42.
go back to reference Ahima RS, Lazar MA. The health risk of obesity—better metrics imperative. Science. 2013;341(6148):856–8. CrossRef Ahima RS, Lazar MA. The health risk of obesity—better metrics imperative. Science. 2013;341(6148):856–8. CrossRef
44.
go back to reference Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010;39(2):417–20. CrossRef Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010;39(2):417–20. CrossRef
45.
go back to reference Banack HR, Kaufman JS. From bad to worse: collider stratification amplifies confounding bias in the “obesity paradox.” Eur J Epidemiol. 2015;30(10):1111–4. CrossRef Banack HR, Kaufman JS. From bad to worse: collider stratification amplifies confounding bias in the “obesity paradox.” Eur J Epidemiol. 2015;30(10):1111–4. CrossRef
46.
go back to reference Guo Y, Zhang T, Wang Z, Yu F, Xu Q, Guo W, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysis. Medicine (Baltimore). 2016;95(28):e4225-e. CrossRef Guo Y, Zhang T, Wang Z, Yu F, Xu Q, Guo W, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysis. Medicine (Baltimore). 2016;95(28):e4225-e. CrossRef
47.
go back to reference Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101(9):1954–60. CrossRef Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101(9):1954–60. CrossRef
48.
go back to reference Brigham E, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, et al. Challenging the obesity paradox: effect of extreme obesity on COPD mortality in patients with heightened cardiovascular risk. D104 Phenotypes and the multiple dimensions of COPD. 2018. p. A7495–A7495. Brigham E, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, et al. Challenging the obesity paradox: effect of extreme obesity on COPD mortality in patients with heightened cardiovascular risk. D104 Phenotypes and the multiple dimensions of COPD. 2018. p. A7495–A7495.
49.
go back to reference Lim JU, Lee JH, Kim JS, Hwang YI, Kim T-H, Lim SY, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. Int J Chronic Obstr Pulm Dis. 2017;12:2465–75. CrossRef Lim JU, Lee JH, Kim JS, Hwang YI, Kim T-H, Lim SY, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. Int J Chronic Obstr Pulm Dis. 2017;12:2465–75. CrossRef
51.
go back to reference De La Cruz-Muñoz N, Lopez-Mitnik G, Arheart KL, Miller TL, Lipshultz SE, Messiah SE. Effectiveness of bariatric surgery in reducing weight and body mass index among Hispanic adolescents. Obes Surg. 2013;23(2):150–6. De La Cruz-Muñoz N, Lopez-Mitnik G, Arheart KL, Miller TL, Lipshultz SE, Messiah SE. Effectiveness of bariatric surgery in reducing weight and body mass index among Hispanic adolescents. Obes Surg. 2013;23(2):150–6.
52.
go back to reference Gulliford MC, Charlton J, Prevost T, Booth H, Fildes A, Ashworth M, et al. Costs and outcomes of increasing access to bariatric surgery: cohort study and cost-effectiveness analysis using electronic health records. Value Health. 2017;20(1):85–92. CrossRef Gulliford MC, Charlton J, Prevost T, Booth H, Fildes A, Ashworth M, et al. Costs and outcomes of increasing access to bariatric surgery: cohort study and cost-effectiveness analysis using electronic health records. Value Health. 2017;20(1):85–92. CrossRef
53.
go back to reference Goto T, Tsugawa Y, Faridi MK, Camargo CA Jr, Hasegawa K. Reduced risk of acute exacerbation of COPD after bariatric surgery: a self-controlled case series study. Chest. 2018;153(3):611–7. CrossRef Goto T, Tsugawa Y, Faridi MK, Camargo CA Jr, Hasegawa K. Reduced risk of acute exacerbation of COPD after bariatric surgery: a self-controlled case series study. Chest. 2018;153(3):611–7. CrossRef
54.
go back to reference Mehring M, Donnachie E, Fexer J, Hofmann F, Schneider A. Disease management programs for patients with COPD in Germany: a longitudinal evaluation of routinely collected patient records. Respir Care. 2014;59(7):1123–32. CrossRef Mehring M, Donnachie E, Fexer J, Hofmann F, Schneider A. Disease management programs for patients with COPD in Germany: a longitudinal evaluation of routinely collected patient records. Respir Care. 2014;59(7):1123–32. CrossRef
Metadata
Title
The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data
Authors
Manuel B. Huber
Christoph Kurz
Florian Kirsch
Larissa Schwarzkopf
Anja Schramm
Reiner Leidl
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2020
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-01556-0

Other articles of this Issue 1/2020

Respiratory Research 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.